IVF with PGT-A and PGT-M in Istanbul

IVF with PGT-A and PGT-M in Istanbul is often searched by couples who want to understand embryo genetics before transfer, especially in cases of advanced maternal age, recurrent miscarriage, previous IVF failure, or a known inherited condition in the family. At Fertiliv, embryo genetic testing is explained as part of an IVF plan, not as a separate test that fits every patient. The key questions are when PGT is useful, what the difference is between PGT-A and PGT-M, how the process works, and how it may affect cost and timeline for international patients.

What is IVF with PGT-A and PGT-M in Istanbul?

IVF with PGT means embryos are created in the laboratory, then a small sample of embryo cells is tested genetically before selecting an embryo for transfer. The test does not treat the embryo or correct a genetic condition. It provides additional information to guide embryo selection. The purpose of testing depends on whether the goal is chromosome screening or testing for a known inherited disease.

What is preimplantation genetic testing?

Preimplantation genetic testing is genetic analysis performed on cells from oocytes or embryos before embryo transfer. ESHRE describes PGT as analysis of DNA from embryos or polar bodies to assess genetic or chromosomal abnormalities before transfer decisions are made. This requires coordination between the IVF team, embryology laboratory, genetic laboratory, and embryo transfer plan.

What is the difference between PGT-A and PGT-M?

PGT-A evaluates embryo chromosome number and helps identify embryos that appear chromosomally normal or abnormal. PGT-M is used when there is a known monogenic disease risk in the family and the embryo is tested for that specific condition. ASRM explains that PGT-M is highly individualized because it often requires genetic counseling, variant confirmation, case review, and customized laboratory test development before the IVF cycle begins.

When can embryo genetic testing be appropriate?

Embryo testing may be appropriate when there is a clear medical indication, such as a known inherited condition, recurrent miscarriage, previous IVF failure, or selected cases involving advanced maternal age. It is not necessary for every couple. ASRM notes that the value of PGT-A as routine screening for all IVF patients has not been demonstrated, so the decision should be individualized.

Which patients may benefit from PGT-A?

Many patients search for PGT-A in Turkey because they want to reduce the chance of transferring an embryo with the wrong number of chromosomes. PGT-A may help in selected cases, but it does not guarantee pregnancy and does not replace the importance of egg quality, embryo development, uterine readiness, and overall health.

How does female age affect chromosome abnormalities?

As female age increases, the chance of chromosomal abnormalities in eggs and embryos generally rises. This can affect implantation and miscarriage risk. PGT-A may be discussed for selected older patients when there are enough embryos to test. If embryo number is very low, the expected benefit should be discussed carefully before adding testing.

Can PGT-A help in recurrent miscarriage?

PGT-A may be discussed in some recurrent miscarriage cases, especially when embryo chromosome abnormalities are suspected. However, recurrent miscarriage can have many causes, including uterine, hormonal, genetic, immune-related in selected cases, or unexplained factors. PGT-A should therefore be part of a broader evaluation, not an automatic answer for every miscarriage history.

What is the role of embryo quality in the PGT-A decision?

Embryo appearance and development help embryologists select embryos, but morphology does not always show chromosome status. PGT-A can add genetic information that is not visible under the microscope. Still, its value depends on the patient’s age, number of embryos, previous history, and treatment goals.

When is PGT-M used?

PGT-M in Turkey is used when a couple has a known risk of passing a specific monogenic condition to a child. This is different from PGT-A because the test looks for a particular disease-causing variant rather than screening chromosome number only. It usually requires preparation before the IVF cycle.

Which single-gene diseases can be tested?

Single-gene diseases are caused by a defined change in a specific gene. They may be autosomal recessive, autosomal dominant, X-linked, or related to a known familial variant. ASRM describes a wide range of possible PGT-M indications, including serious inherited conditions and some adult-onset disorders, but each family requires individualized genetic review.

Why does a known family genetic condition matter?

A known genetic diagnosis makes PGT-M possible because the laboratory needs to know which gene or variant to test. If the family does not have a clear genetic report, additional testing may be required before IVF. PGT-M does not begin with a general wish to “check embryos”; it begins with a specific genetic question.

Why is genetic counseling important before IVF with PGT-M?

Genetic counseling helps the couple understand the disease, inheritance pattern, transmission risk, test limitations, and possible unclear results. ASRM recommends genetic counseling about the condition and reproductive options before PGT-M, because the process is complex and often requires customized laboratory preparation.

How does IVF with PGT work?

IVF with PGT combines standard IVF steps with additional embryology and genetic testing steps. The ovaries are stimulated, eggs are retrieved, sperm is prepared, embryos are created, embryo cells are biopsied, the sample is tested, and embryos are selected for transfer according to the results and medical plan.

How are embryos created in the laboratory?

The process begins with ovarian stimulation to obtain multiple eggs. Eggs are retrieved and sperm is prepared. Fertilization is then performed in the laboratory. ICSI is often used in PGT cycles to reduce the risk of genetic sample contamination from surrounding sperm. Embryos are then cultured until they reach the stage suitable for biopsy.

How is an embryo biopsy performed?

In many modern PGT protocols, biopsy is performed at the blastocyst stage from cells that later contribute to the placenta. ESHRE recommendations emphasize that embryo biopsy, sample handling, cryopreservation, and laboratory technique require careful practice because these steps affect result reliability.

How is the sample analyzed and embryos selected?

The biopsy sample is tested according to the planned method. PGT-A assesses chromosome number, while PGT-M looks for a known inherited condition. Embryos are often frozen after biopsy while results are pending. If a suitable embryo is available, transfer is usually planned in a later frozen embryo transfer cycle.

Can all embryos be transferred after testing?

No. The purpose of testing is not to transfer all embryos but to identify which embryos are suitable for transfer based on the result. Some embryos may test normal, some abnormal, and some results may be inconclusive. Couples should understand that PGT may reduce the number of embryos available for transfer, but it can support more informed decision-making.

What do embryo genetic test results mean?

In PGT-A, results may show chromosomally normal, abnormal, mosaic in some laboratories, or inconclusive embryos. In PGT-M, results may show embryos that are unaffected, affected, carriers in some recessive conditions, or unclear. The meaning depends on the type of test, the condition, and the laboratory report, so results should be explained before transfer decisions are made.

What is the difference between normal, abnormal, and inconclusive embryos?

A normal PGT-A result means the tested sample appears to have the expected chromosome number. An abnormal result means a clear chromosome imbalance was detected. An inconclusive result means the sample did not provide enough reliable information, and repeat biopsy or case-specific decision-making may be considered. PGT results guide selection, but they do not guarantee pregnancy.

How is the embryo transfer decision made after PGT?

The embryo transfer decision depends on test results, embryo quality, female age, previous treatment history, uterine lining, and the couple’s informed preference. Single embryo transfer may be recommended in suitable cases to reduce the risk of multiple pregnancy, a principle supported in fertility care discussions about safer embryo transfer.

IVF cost with PGT-A and PGT-M in Istanbul

IVF cost with PGT-A and PGT-M in Istanbul is different from the cost of a basic IVF cycle because the plan may include embryo biopsy, genetic analysis, embryo freezing, storage, and later frozen embryo transfer. Patients comparing PGT-A cost in Turkey or PGT-M cost in Turkey should review the full treatment plan, not only the genetic test fee.

What is included in the basic IVF cycle cost?

A basic IVF cycle may include monitoring, egg retrieval, fertilization, embryo culture, and embryo transfer depending on the program. When PGT is added, embryos are often frozen while results are processed, and transfer may happen later. Patients should ask whether ICSI, medications, blood tests, freezing, and frozen embryo transfer are included.

How is genetic testing cost calculated?

Genetic testing may be calculated per embryo, as a package for a certain number of embryos, or as a combination of setup and analysis fees. PGT-M may include additional preparation before the cycle because the test is tailored to the family’s known condition. A written cost explanation should clarify how pricing changes if more embryos are biopsied.

Which factors affect the final cost?

Final cost may be affected by the number of embryos tested, whether the test is PGT-A or PGT-M, genetic preparation, ICSI, embryo freezing, storage duration, frozen embryo transfer, and any additional tests or procedures before treatment. The final estimate becomes clearer after medical review and treatment planning.

What is the treatment journey for international patients in Istanbul?

International patients need careful planning before travel because IVF with PGT may require more than one visit or a waiting period for genetic results. Istanbul can be practical for patients traveling from abroad, but the experience depends on having a clear treatment plan, completed pre-travel tests, and realistic expectations about timing.

What tests are needed before traveling?

Pre-travel tests may include AMH, ultrasound, hormone tests, semen analysis, infection screening, and genetic reports if PGT-M is planned. For inherited diseases, the known variant or family genetic report should be sent early because the genetic laboratory may need case review and preparation before IVF begins.

What is the timeline for IVF with PGT?

The timeline may include ovarian stimulation, egg retrieval, fertilization, embryo development, embryo biopsy, freezing, genetic analysis, and later embryo transfer. In many cases, the journey is divided into two stages: one visit for embryo creation and testing, and another visit for frozen embryo transfer after results are available.

How does follow-up work after embryo transfer?

After embryo transfer, the patient continues medications and follows instructions until the pregnancy test date. International patients can often complete beta-hCG testing and early follow-up locally after returning home. Medication should not be stopped because of mild symptoms or light bleeding without medical instruction.

Conclusion

IVF with PGT-A and PGT-M in Istanbul may be important for selected couples, especially when there is a known inherited disease, recurrent miscarriage, previous IVF failure, or age-related concern about embryo chromosomes. However, embryo genetic testing is not required for every patient and does not guarantee pregnancy. It is a tool that helps guide embryo selection using additional genetic information.

If you are considering IVF with PGT-A or PGT-M in Istanbul, you can book a consultation with the Fertiliv team to discuss your case, understand the difference between embryo testing options, and decide whether genetic testing is appropriate for your treatment plan.

Frequently Asked Questions: IVF with PGT-A and PGT-M in Istanbul

Does PGT-A improve IVF success?

PGT-A may help select chromosomally normal embryos in selected cases, but it does not guarantee pregnancy and is not necessary for everyone.

What is the difference between PGT-A and PGT-M?

PGT-A checks embryo chromosome number, while PGT-M tests for a specific inherited condition known in the family.

Does PGT-M require preparation before IVF?

Yes. It often requires genetic counseling, variant confirmation, and customized test preparation before the IVF cycle.

Is embryo transfer done in the same cycle?

Often embryos are frozen after biopsy while results are pending, and transfer is planned later in a frozen embryo transfer cycle.

Is PGT-A or PGT-M cost fixed?

No. Cost depends on test type, number of embryos, genetic setup, freezing, storage, and frozen embryo transfer.